Kwarlay.com

Navigating the News Maze with Clarity

    • Medicine

    FDA Approves Pfizer’s Adcetris for Relapsed or Refractory Large B-Cell Lymphoma

    admin Posted on

    Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ineligible for autologous stem cell transplantation.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Slot
    TOGEL ONLINE